• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Brain . Neurovascular injury with complement activation and inflammation in COVID-19

tetano

Editor, Senior Moderator
Brain


. 2022 Jul 5;awac151.
doi: 10.1093/brain/awac151. Online ahead of print.
Neurovascular injury with complement activation and inflammation in COVID-19


Myoung Hwa Lee[SUP] 1 [/SUP], Daniel P Perl[SUP] 2 [/SUP], Joseph Steiner[SUP] 1 [/SUP], Nicholas Pasternack[SUP] 1 [/SUP], Wenxue Li[SUP] 1 [/SUP], Dragan Maric[SUP] 1 [/SUP], Farinaz Safavi[SUP] 1 [/SUP], Iren Horkayne-Szakaly[SUP] 3 [/SUP], Robert Jones[SUP] 3 [/SUP], Michelle N Stram[SUP] 4 [/SUP], Joel T Moncur[SUP] 3 [/SUP], Marco Hefti[SUP] 5 [/SUP], Rebecca D Folkerth[SUP] 4 [/SUP], Avindra Nath[SUP] 1 [/SUP]



Affiliations

Abstract

The underlying mechanisms by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to acute and long-term neurological manifestations remains obscure. We aimed to characterize the neuropathological changes in patients with coronavirus disease 2019 and determine the underlying pathophysiological mechanisms. In this autopsy study of the brain, we characterized the vascular pathology, the neuroinflammatory changes and cellular and humoral immune responses by immunohistochemistry. All patients died during the first wave of the pandemic from March to July 2020. All patients were adults who died after a short duration of the infection, some had died suddenly with minimal respiratory involvement. Infection with SARS-CoV-2 was confirmed on ante-mortem or post-mortem testing. Descriptive analysis of the pathological changes and quantitative analyses of the infiltrates and vascular changes were performed. All patients had multifocal vascular damage as determined by leakage of serum proteins into the brain parenchyma. This was accompanied by widespread endothelial cell activation. Platelet aggregates and microthrombi were found adherent to the endothelial cells along vascular lumina. Immune complexes with activation of the classical complement pathway were found on the endothelial cells and platelets. Perivascular infiltrates consisted of predominantly macrophages and some CD8+ T cells. Only rare CD4+ T cells and CD20+ B cells were present. Astrogliosis was also prominent in the perivascular regions. Microglial nodules were predominant in the hindbrain, which were associated with focal neuronal loss and neuronophagia. Antibody-mediated cytotoxicity directed against the endothelial cells is the most likely initiating event that leads to vascular leakage, platelet aggregation, neuroinflammation and neuronal injury. Therapeutic modalities directed against immune complexes should be considered.

Keywords: COVID-19; SARS-CoV-2; complement deposition; neuroinflammation; neurovascular injury.
 
Back
Top Bottom